These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6267100)

  • 1. Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.
    Chisari FV; Curtiss LK; Jensen FC
    J Clin Invest; 1981 Aug; 68(2):329-36. PubMed ID: 6267100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regions of the EBV genome involved in latency and lymphocyte immortalization.
    Miller G
    Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuramide inhibits Epstein-Barr virus-induced transformation activity and proliferation of transformed B lymphocytes.
    Venanzoni MC; Angeloni A; Di Muzio M; Faggioni A; Frati L
    Antiviral Res; 1997 Feb; 33(3):177-85. PubMed ID: 9037374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
    Straub C; Zubler RH
    J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells.
    Bende RJ; Jochems GJ; Frame TH; Klein MR; van Eijk RV; van Lier RA; Zeijlemaker WP
    Cell Immunol; 1992 Sep; 143(2):310-23. PubMed ID: 1324802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes.
    Alfieri C; Allison AC; Kieff E
    Antimicrob Agents Chemother; 1994 Jan; 38(1):126-9. PubMed ID: 8141564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities.
    Yao QY; Czarnecka H; Rickinson AB
    Int J Cancer; 1991 May; 48(2):253-7. PubMed ID: 1850387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epstein-Barr virus associated lymphocyte proliferation].
    Stein H; Hummel M; Anagnostopoulos I; Korbjuhn P; Niedobitek G; Dallenbach F; Herbst H
    Verh Dtsch Ges Pathol; 1992; 76():79-95. PubMed ID: 1283280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.
    Chodosh J; Holder VP; Gan YJ; Belgaumi A; Sample J; Sixbey JW
    J Infect Dis; 1998 May; 177(5):1194-201. PubMed ID: 9593003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization.
    Brielmeier M; Mautner J; Laux G; Hammerschmidt W
    J Gen Virol; 1996 Nov; 77 ( Pt 11)():2807-18. PubMed ID: 8922475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus persistence and virus-associated tumours.
    Niedobitek G; Young LS
    Lancet; 1994 Feb; 343(8893):333-5. PubMed ID: 7905149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.
    Burdin N; Péronne C; Banchereau J; Rousset F
    J Exp Med; 1993 Feb; 177(2):295-304. PubMed ID: 8381152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
    Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
    Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.